Exor NV
Exor announces the launch of a Tender Offer to repurchase up to €750 Million in Ordinary Shares as part of its new €1 Billion Share Buyback Program
Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal value of EUR 0.01 each in the share capital of Exor N.V. (each an “Ordinary Share”, and together the “Ordinary Shares”), executed via a reverse “Dutch auction”, for an aggregate consideration up to (and including) €750 million to Qualifying Shareholders (as defined below) (the “Tender Offer”).
Exor’s Board of Directors approves Half-Year 2023 Results and announces €1bn share buyback program
EXOR DELIVERS 23% GROWTH IN NAV PER SHARE IN H1,
OUTPERFORMING MSCI BY 11 p.p.
€1 BILLION BUYBACK PROGRAM ANNOUNCED
WITH TENDER OFFER AT UP TO 10% PREMIUM
• Exor reports NAV of €34.2 billion at 30 June 2023. NAV per share increased 22.8% over the first half of 2023, while outperforming the MSCI World Index by 11.3 p.p., mainly driven by the market performance of Listed Companies.
Exor becomes a long-term investor in Philips supporting the company’s strategy
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, and Exor N.V. (AEX: EXO), the Netherlands-based diversified holding company, announce they have entered into a relationship agreement as a result of which Exor has bought a 15% shareholding in Philips.